- News
- Markus Manns
Tag:
Markus Manns
-
Danish drugmaker Novo Nordisk has agreed on a Medicare pricing deal for semaglutide, the active ingredient in its blockbuster weight-loss and diabetes drugs Ozempic and Wegovy, easing investor concerns over steep U.S. pricing cuts.05 Nov 2025-14:15
-